FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088973856> ?p ?o ?g. }

• W3088973856 endingPage "9075" @default.
• W3088973856 startingPage "9067" @default.
• W3088973856 abstract "When used for cervical cancer primary screening, liquid-based cytology (LBC) has a high specificity but a low sensitivity. For histological diagnosis of high-grade lesions, p16INK4a immunostaining has proven to be useful. Therefore, our objective was to evaluate the use of p16INK4a immuno-cytology as a primary screen and a secondary screen after primary high-risk human papillomavirus (hrHPV) screening or LBC screening.A total of 1197 cytology slides were immuno-stained using automatic p16INK4a staining system (PathCIN®p16INK4a) in two studies from cervical screening programs. In the primary screening study, 875 slides were randomly selected and analyzed for p16INK4a. In the secondary screening study, 322 of the remaining slides were chosen by virtue of being HPV 16/18+, other hrHPV+/LBC≥ASC-US, or HPV-negative/LBC ≥LSIL. The sensitivity and specificity for detection of cervical intraepithelial neoplasia 2/3 or worse (CIN2+/CIN3+) were compared based on p16INK4a, LBC and HPV test results.In combining two studies, there were 431 cases with biopsy pathology. They included 83 cases with CIN2+ and 41 cases with CIN3+. The p16 positivity rate increased with pathologic and cytologic severity (P<0.0001). For primary screening: p16 immuno-cytology was more specific than HPV testing and was similar in sensitivity. Also, p16 immuno-cytology compared favorably with routine LBC (≥ASC-US or ≥LSIL) in sensitivity and specificity. For secondary screening: after LBC screening, Triaging ASC-US with p16 gave a higher specificity and a similar sensitivity as compared to the Triaging ASC-US with hrHPV algorithm. After HPV primary screening, p16 immuno-cytology was more specific than LBC (≥ASC-US); the calculated colposcopy referral rate was also decreased by using p16 immuno-cytology as triage. Triage of HPV16/18 and p16 had higher specificity and similar sensitivity as compared to triage of HPV16/18 and LBC ≥ASC-US.For primary screening, p16INK4a immuno-cytology compares favorably to routine LBC and HPV testing. p16INK4a immunostaining could be an efficient triage to reduce the colposcopy referral rate after primary hrHPV screening or LBC screening. Therefore, p16INK4a immuno-cytology may be applicable as a favorable technology for cervical cancer screening." @default.
• W3088973856 created "2020-10-01" @default.
• W3088973856 creator A5005352328 @default.
• W3088973856 creator A5005782060 @default.
• W3088973856 creator A5007054845 @default.
• W3088973856 creator A5021811512 @default.
• W3088973856 creator A5023144583 @default.
• W3088973856 creator A5030968272 @default.
• W3088973856 creator A5034790923 @default.
• W3088973856 creator A5038654266 @default.
• W3088973856 creator A5081239659 @default.
• W3088973856 creator A5082709549 @default.
• W3088973856 date "2020-09-01" @default.
• W3088973856 modified "2023-09-23" @default.
• W3088973856 title "<p>Evaluating the Performance of p16^INK4a Immunocytochemistry in Cervical Cancer Screening</p>" @default.
• W3088973856 cites W1520483630 @default.
• W3088973856 cites W1970828076 @default.
• W3088973856 cites W1974915741 @default.
• W3088973856 cites W2027670630 @default.
• W3088973856 cites W2033960375 @default.
• W3088973856 cites W2041896049 @default.
• W3088973856 cites W2073439462 @default.
• W3088973856 cites W2109840766 @default.
• W3088973856 cites W2117497925 @default.
• W3088973856 cites W2121732950 @default.
• W3088973856 cites W2124327706 @default.
• W3088973856 cites W2131727603 @default.
• W3088973856 cites W2148265011 @default.
• W3088973856 cites W2166467087 @default.
• W3088973856 cites W2346877206 @default.
• W3088973856 cites W2468321422 @default.
• W3088973856 cites W2531643489 @default.
• W3088973856 cites W2905431093 @default.
• W3088973856 cites W2971680537 @default.
• W3088973856 cites W2972660063 @default.
• W3088973856 cites W3001464222 @default.
• W3088973856 cites W3002413794 @default.
• W3088973856 cites W3024858697 @default.
• W3088973856 doi "https://doi.org/10.2147/cmar.s273079" @default.
• W3088973856 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7524171" @default.
• W3088973856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33061601" @default.
• W3088973856 hasPublicationYear "2020" @default.
• W3088973856 type Work @default.
• W3088973856 sameAs 3088973856 @default.
• W3088973856 citedByCount "7" @default.
• W3088973856 countsByYear W30889738562020 @default.
• W3088973856 countsByYear W30889738562021 @default.
• W3088973856 countsByYear W30889738562022 @default.
• W3088973856 countsByYear W30889738562023 @default.
• W3088973856 crossrefType "journal-article" @default.
• W3088973856 hasAuthorship W3088973856A5005352328 @default.
• W3088973856 hasAuthorship W3088973856A5005782060 @default.
• W3088973856 hasAuthorship W3088973856A5007054845 @default.
• W3088973856 hasAuthorship W3088973856A5021811512 @default.
• W3088973856 hasAuthorship W3088973856A5023144583 @default.
• W3088973856 hasAuthorship W3088973856A5030968272 @default.
• W3088973856 hasAuthorship W3088973856A5034790923 @default.
• W3088973856 hasAuthorship W3088973856A5038654266 @default.
• W3088973856 hasAuthorship W3088973856A5081239659 @default.
• W3088973856 hasAuthorship W3088973856A5082709549 @default.
• W3088973856 hasBestOaLocation W30889738561 @default.
• W3088973856 hasConcept C121608353 @default.
• W3088973856 hasConcept C126322002 @default.
• W3088973856 hasConcept C142724271 @default.
• W3088973856 hasConcept C143998085 @default.
• W3088973856 hasConcept C18823058 @default.
• W3088973856 hasConcept C2775934546 @default.
• W3088973856 hasConcept C2776117191 @default.
• W3088973856 hasConcept C2776136576 @default.
• W3088973856 hasConcept C2777343196 @default.
• W3088973856 hasConcept C2778220009 @default.
• W3088973856 hasConcept C2780647465 @default.
• W3088973856 hasConcept C29456083 @default.
• W3088973856 hasConcept C2993522905 @default.
• W3088973856 hasConcept C71924100 @default.
• W3088973856 hasConcept C90924648 @default.
• W3088973856 hasConceptScore W3088973856C121608353 @default.
• W3088973856 hasConceptScore W3088973856C126322002 @default.
• W3088973856 hasConceptScore W3088973856C142724271 @default.
• W3088973856 hasConceptScore W3088973856C143998085 @default.
• W3088973856 hasConceptScore W3088973856C18823058 @default.
• W3088973856 hasConceptScore W3088973856C2775934546 @default.
• W3088973856 hasConceptScore W3088973856C2776117191 @default.
• W3088973856 hasConceptScore W3088973856C2776136576 @default.
• W3088973856 hasConceptScore W3088973856C2777343196 @default.
• W3088973856 hasConceptScore W3088973856C2778220009 @default.
• W3088973856 hasConceptScore W3088973856C2780647465 @default.
• W3088973856 hasConceptScore W3088973856C29456083 @default.
• W3088973856 hasConceptScore W3088973856C2993522905 @default.
• W3088973856 hasConceptScore W3088973856C71924100 @default.
• W3088973856 hasConceptScore W3088973856C90924648 @default.
• W3088973856 hasLocation W30889738561 @default.
• W3088973856 hasLocation W30889738562 @default.
• W3088973856 hasLocation W30889738563 @default.
• W3088973856 hasOpenAccess W3088973856 @default.
• W3088973856 hasPrimaryLocation W30889738561 @default.
• W3088973856 hasRelatedWork W1517644390 @default.
• W3088973856 hasRelatedWork W1536780471 @default.

• next